TITAN PHARMACEUTICALS INC DE's ticker is TTNP and the CUSIP is 888314309. A total of 47 filers reported holding TITAN PHARMACEUTICALS INC DE in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $136,000 | – | 71,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GAGNON SECURITIES LLC | 62,219 | $340,000 | 0.16% |
| THOMPSON DAVIS & CO., INC. | 16,184 | $89,000 | 0.14% |
| Blume Capital Management, Inc. | 2,546 | $14,000 | 0.01% |
| BLUESTEIN R H & CO LLC | 20,000 | $109,000 | 0.01% |
| Virtu KCG Holdings LLC | 49,157 | $269,000 | 0.01% |
| Spark Investment Management LLC | 11,000 | $60,000 | 0.01% |
| Spot Trading L.L.C | 62,300 | $341,000 | 0.01% |
| Acrospire Investment Management LLC | 1,270 | $7,000 | 0.01% |
| ACCURATE INVESTMENT SOLUTIONS, INC. | 1,000 | $5,000 | 0.01% |
| ARCADIA INVESTMENT MANAGEMENT CORP/MI | 1,819 | $10,000 | 0.00% |